(EMAILWIRE.COM, May 09, 2015 ) GBI ResearchÂ’s analyses identified 122 first-in-class programs in active development, constituting 13.6% of the pipeline and acting on 65 first-in-class molecular targets, indicating a high degree of innovation. This is in stark contrast to the pain therapeutics market,…
http://www.emailwire.com/release/185045-Frontier-Pharma-Pain-Identifying-and-Commercializing-FirstinClass-Innovation.html
Frontier Pharma: Pain – Identifying and Commercializing First-in-Class Innovation
Related Posts
Recent News
About Us
Market Press Newswire™ provides press release distribution services for businesses,organizations that provide market research reports. The press releases are published
across the webs. Other services include press release writing, editing,consulting and media planning.
Recent Post
Recent Posts
- Kaafmeem to Provide VIP Clothing for Saudi Motorsport Company during Formula1 event in KSA.
- Correction: BioMap and MBZUAI team up on joint biocomputing lab to promote sustainable development and human health in the Middle East
- Electrolyzers Market worth $23.6 Billion by 2028
- Air Motor Market expected to hit USD 1.08 Bn by 2029 during the forecast period
Subscribe Our Newsletter
MarketPressNewswire.net™ is part of GroupWeb Media Network. © 2023 GroupWeb Media LLC